What adult meropenem dose is typically used (and for what infection)?
Meropenem dosing in adults depends on the infection site, severity, kidney function, and whether the infection is hospital-acquired/complicated. Common adult regimens in clinical practice include:
- Intra-abdominal infections (including complicated cases): often 1 g IV every 8 hours
- Pneumonia (including hospital-acquired): often 1 g IV every 8 hours
- Skin/skin-structure infections (including complicated): often 1 g IV every 8 hours
- Urinary tract infections (complicated): often 500 mg to 1 g IV every 8 hours depending on severity
- Severe infections such as sepsis: often 1 g IV every 8 hours
Doses may be increased in life-threatening or hard-to-treat infections (guided by local protocols and susceptibility results).
What changes when kidney function is reduced?
Meropenem is cleared by the kidneys, so adult dosing is adjusted by creatinine clearance (CrCl) to avoid drug accumulation and increased risk of adverse effects, particularly neurologic effects (e.g., seizures).
General pattern:
- Normal renal function: usually 1 g IV every 8 hours for many serious infections
- Moderate to severe renal impairment: dosing interval is often extended (less frequent doses) and/or the dose is reduced
Exact dose/interval should be matched to the specific dosing table used by your hospital/pharmacy and the patient’s measured CrCl or eGFR.
What dosing interval is most common: every 8 hours or every 6 hours?
A frequent default for adults with serious infections is every 8 hours (q8h). Some clinicians may use more frequent dosing (e.g., q6h) in certain severe infections or based on local extended/optimized dosing strategies, but this depends on protocols, infection severity, and renal function.
How is meropenem given (IV push vs infusion)?
Meropenem is administered intravenously. Many regimens are given as an IV infusion rather than a rapid push, especially in settings using extended dosing strategies to improve time above the MIC (minimum inhibitory concentration). Your specific product instructions and facility protocol govern administration details.
What if the patient is critically ill or has very high clearance?
In critically ill patients, kidney function and drug clearance can be variable (sometimes higher than expected). Clinicians may adjust to ensure adequate exposure, which can mean shorter dosing intervals or extended infusion strategies, guided by local practice and renal trends.
Important safety issues patients and clinicians watch for
- Allergy: avoid use in patients with a history of serious hypersensitivity to carbapenems.
- Seizure risk: risk increases with renal impairment, high meropenem exposure, or other pro-convulsant factors.
- C. difficile diarrhea: like other broad-spectrum antibiotics, meropenem can increase risk.
If you share the patient’s age, weight, estimated creatinine clearance/eGFR, infection type (e.g., pneumonia vs UTI vs intra-abdominal), and severity, I can help narrow to the most appropriate adult meropenem dosing range and the usual renal adjustment direction.